T-Zellrezeptorpresentation

European patent · EP2048159 · Deleted

Register entry

Publication number
EP2048159
Application number
EP09001469
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 30, 2003
Published
Apr 15, 2009
Granted
Jan 1, 2014
Deleted
Oct 30, 2023
Reason
Maximum term reached
IPC classes
C07K 14/705 (2006.01)
C12N 7/00 (2006.01)
C12N 15/10 (2006.01)
Priority
GB 0226227 09.11.2002
GB 0301814 25.01.2003
GB 0304067 22.02.2003
US 463046 P 16.04.2003
GB 0311397 16.05.2003
GB 0316356 11.07.2003
Divided from
EP03811009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 30, 2023

    Maximum term reached

    Published in Swissreg on 30.10.2023

  2. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  3. Jan 16, 2014

    Agent entered

    Representative
    Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano

    Published in Swissreg on 16.01.2014

  4. Jan 1, 2014

    Granted

    Published in Swissreg on 01.01.2014

Parties

Holder

Immunocore Ltd.

57c Milton Park, Abingdon Oxford OX14 4RX, GB

Adaptimmune Limited

9400 Garsington Road, Oxford Business Park Oxford OX2 2HN, GB

Agent

FIAMMENGHI - FIAMMENGHI

Fiammenghi-Fiammenghi

Via San Gottardo 15, 6900 Lugano

Struck from the register

Inventor

Jakobsen, Bent Karsten

Abingdon, Oxford OX14 4RX, GB

Andersen, Torben Bent

Abingdon, Oxford OX14 4RX, GB

Molloy, Peter Eamon

Abingdon, Oxford OX14 4RX, GB

Li, Yi

Abingdon, Oxford OX14 4RX, GB

Boulter, Jonathan Michael

deceased, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.